• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of March 6, 2013

  • Print
  • Share
  • E-mail
-

Event Detail

Event ID 64317
Product Type Drugs
Status Ongoing
Recalling Firm Actavis Pharmaceuticals
City Morristown
State NJ
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-01-04
Initial Firm Notification of
Consignee or Public
Letter
Distribution Pattern Nationwide

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217 Lot CB1D05A, Class III Failed Dissolution Specifications; 8-hours for the 18-month stability testing point. 14,856 bottles D-175-2013
-
-